Administering oral doses of the antibiotic azithromycin to pregnant individuals could potentially serve as a cost-effective measure for mitigating maternal sepsis, mortality, or infection in developing nations. This conclusion stems from a study incorporating data from seven countries, including India.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.